Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 2Phase 2 2Phase 1/2 2

Status

Completed 8Terminated 4Active not recruiting 2

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Melanoma 1Hematologic Neoplasms 1Disease 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 98pembrolizumab 87Gemcitabine 81Carboplatin 63fludarabine 62Nivolumab 57Cisplatin 54Paclitaxel 51Radiotherapy 50Docetaxel 50Rituximab 46Dexamethasone 42Lenalidomide 41Ipilimumab 38Azacitidine 35Etoposide 34Cytarabine 34Temozolomide 32Bevacizumab 32Radiation 29venetoclax 28Bortezomib 27Magnetic Resonance Spectroscopy 26Irinotecan 26atezolizumab 25Pemetrexed 25Oxaliplatin 24Capecitabine 24fludarabine phosphate 23Filgrastim 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Terminated × alovudine × Clear all
NCT00633958 2021-10-20

FLT

Dana-Farber Cancer Institute

Phase 1 Terminated
2 enrolled
CNS

Disease, Central Nervous System Neoplasms

NCT02891616 2019-07-17

18F-FLT PET Imaging in Patients With Advanced Melanoma

Washington University School of Medicine

Phase 1 Terminated
4 enrolled
Dermatologic

Melanoma

NCT01283178 2016-10-31

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

Virginia Commonwealth University

Phase 1 Terminated
3 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms

NCT00070239 2013-12-16

Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies

National Cancer Institute (NCI)

Phase 1 Terminated
100 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡